US Patent 9738716 Beta klotho binding proteins and methods of use thereof
Patent 9738716 was granted and assigned to NGM Biopharmaceuticals on August, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+162 characters)
Article
Patent abstract
The present disclosure provides binding proteins, such as antibodies, that bind beta klotho, including human beta klotho, and methods of their use.
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09738716 Beta klotho binding proteins and methods of use thereof US Patent 9738716 Beta klotho binding proteins and methods of use thereof
Infobox
Patent Number
0973871600
Patent Number
973871600
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097387160
Date of Patent
August 22, 2017
0Patent Application Number
146045920
Date Filed
January 23, 2015
0Patent Primary Examiner
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097387160
Date of Patent
August 22, 2017
0Patent Application Number
146045920
Date Filed
January 23, 2015
0Patent Primary Examiner
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09738716 Beta klotho binding proteins and methods of use thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09738716
Date of patent
August 22, 2017
Patent application number
14604592
Date Filed
January 23, 2015
Patent primary examiner
Find more entities like US Patent 9738716 Beta klotho binding proteins and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
